ANA Chronicles 40 years of Japanese Video Game History with Dedicated Content
30.10.2019 18:00:00 EET | Business Wire | Press release
All Nippon Airways (ANA), Japan’s largest 5-Star airline for seven consecutive years will launch new content, “IS JAPAN COOL? GAME CHRONICLE,” that focuses on Japanese game culture and seeks to increase awareness of Japan’s contributions to this growing industry. The content will be part of IS JAPAN COOL? website that is designed to promote international tourism in Japan. With the number of game-centric visitors to Japan on the rise, this website is a vital tool in planning travel itineraries.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191030005402/en/
"GAME CHRONICLE" (Graphic: Business Wire)
Video games are the combined product of creators’ imagination and developers’ passion. Japan has long been a trendsetter in video game design and this website offers tourists a crash course in the history of video games and their impact on Japanese culture.
“ANA seeks to act as an ambassador for Japan and its culture on the global stage, and the launch of this new website section will help drive tourism while providing an important educational resource for those interested in video games,” said Takashi Shiki, Senior Executive Vice President of ANA. “Like everything we do, IS JAPAN COOL? has always sought to set the gold standard for tourism websites, and this latest addition certainly goes above and beyond expectations. We invite all visitors to Japan by using IS JAPAN COOL? to help plan their trips.”
Available in English and Chinese, ANA first launched “IS JAPAN COOL?” in 2012 to make Japan more accessible while also introducing the nation’s unique culture and attractions to the world. In addition to its detailed explanation of Japanese culture, IS JAPAN COOL? offers local insight that helps tourists navigate during their visit to Japan. The website features insider information on cities and local prefectures including Tokyo, Okinawa, and Kyoto while providing detailed overviews of Japanese culture such as washoku (Japanese cuisine), contemporary arts, matsuri (festivals), as well as budo and geido (martial arts and performing/fine arts).
This website focuses on Japanese game history at four different stages, breaking it down by decade to highlight achievements in the 1980s, 1990s, 2000s, and 2010s and discussing 100 key topics that exemplify each of the four eras. Giving achievement points for each article read and video watched, this website itself is even structured like a video game to give visitors a memorable experience as they learn more about Japanese video games.
Each decade has a distinct theme, with image resolution and music faithfully being reproduced to evoke the technical limitations and overall aesthetic of each era. This allows visitors to learn about advances in game technology in each era.
Visitors can also watch interviews featuring prominent game experts from developers and creators sharing their behind-the-scenes stories and insider perspectives to professional gamers who offer their views on the industry today. This compelling content is available only on the “IS JAPAN COOL? GAME CHRONICLE” website.
ANA embraces its Japanese roots and is proud to celebrate the many distinct aspects of its culture and history. Video games make up one of Japan’s most important modern culture exports and ANA seeks to welcome the next generation of tourists, particularly those with an interest in video games.
About ANA
Following the “Inspiration of Japan” high quality of service, ANA has been awarded the respected 5-Star rating every year since 2013 from SKYTRAX. ANA is the only Japanese airline to win this prestigious designation seven years in a row. Additionally, ANA has been recognized by Air Transport World as “Airline of the Year” three times in the past 10 years - 2007, 2013 and 2018, becoming one of the few airlines winning this prestigious award for multiple times.
ANA was founded in 1952 with two helicopters and has become the largest airline in Japan, as well as one of the most significant airlines in Asia, operating 82 international routes and 121 domestic routes. ANA offers a unique dual hub model which enables passengers to travel to Tokyo and connect through the two airports in the metropolitan Tokyo, NARITA and HANEDA, to various destinations throughout Japan, and also offers same day connections between various North American, Asian and Chinese cities.
ANA has been a member of Star Alliance since 1999 and has joint venture partnerships with United Airlines, Lufthansa German Airlines, Swiss International Airlines and Austrian Airlines.
Besides the full service and award winner carrier ANA, the ANA Group has two LCCs as consolidated subsidiaries, Vanilla Air Inc. and Peach Aviation Limited. The ANA Group carried 54.4 million passengers in FY2018, has approximately 43,000 employees and a fleet of 260 aircrafts. ANA is a proud launch customer and the biggest operator of the Boeing 787 Dreamliner.
For more information, please refer to the following link.
https://www.ana.co.jp/group/en/
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191030005402/en/
Contact information
“GAME CHRONICLE” PR Office: AUR, Inc.
Ashita Iju (Mr.), Miyabi Ishida (Ms.)
TEL: +81-3-5545-3888
E-mail: ijc_pr-ml@aur.co.jp
Or
ANA Corporate Communications, TEL +81-3-6735-1111, publicrelations@ana.co.jp
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Opzelura ® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 14:30:00 EEST | Press release
Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs) are inadequate or inappropriate. “AD is a chronic skin condition that can have a significant impact on daily life. The positive CHMP opinion for Opzelura marks meaningful progress toward bringing the first non-steroidal topical JAK treatment option to adults in Europe with moderate AD for whom standard topical therapies have failed,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved by the European Commission, Opzelura could help address an important gap for patients who have limited treatment options when TCSs and TCIs are inadequate or inappropriate.” The positive CHMP o
Datroway ® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 14:00:00 EEST | Press release
Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the TROPION-Breast02phase 3 trial, which werepresented at the 2025 European Society for Medical Oncology Congress and published in Annals of Oncology. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In TROPION-Breast02, Datroway demonstrated a
DAYBU ® (trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 13:49:00 EEST | Press release
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating condition," said Catherine Owen Adams, Acadia’s Chief Executive Officer. “Our commitment is to make a meaningful difference in the lives of patients, caregivers, and the wider Rett com
HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 12:18:00 EEST | Press release
HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi
Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 11:28:00 EEST | Press release
Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
